Papers: 10.18632/oncotarget.10852

https://doi.org/10.18632/oncotarget.10852

Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations

Cited by: 23
Author(s): Brendon Ladd, Anne Marie Mazzola, Teeru Bihani, Zhongwu Lai, James R. Bradford, Michael Collins, Evan Barry, Anne U. Goeppert, Hazel M. Weir, Kelly Hearne, Jonathan Renshaw, Morvarid Mohseni, Elaine M. Hurt, Sanjoo Jalla, Haifeng Bao, Robert E. Hollingsworth, Corinne Reimer, Michael Zinda, Stephen E. Fawell, Celina M. D’Cruz
Published: about 9 years ago

Software Mentions 1